research technology and solutions
homeblood disease and transplantation immune disease detection technology programhematopoietic stem cell transplantation donor selection
hematopoietic stem cell transplantation donor selection
the company has a comprehensive and comprehensive donor selection plan for patients with hla, dsa, c1q, kir, mica, sufu, and viruses.
tissue bank donor selection
hla
hematopoietic stem cell transplantation for donor selection
dsa
avoid implant failure and implant failure as donor selection and postoperative test indicators
kri
reduce transplant recurrence rate and improve overall survival rate
mica
predict the occurrence of gvhd
sufu
preoperative testing for gvhd stratification
virus
positive suggestive of viral infection, dynamic monitoring before and after transplantation- clinical service
- clinical cell molecular genetics test
- clinical blood and body fluid testing
- service overview
- knowledge center
- technology latform
- sequencing platform
- diagnostic platform
- computing and data platform
- sample storage platform
- research and technology solutions
- blood disease
- epilepsy medication guidance
- whole genome
- research cooperation
- technical team
- biological reagent
- class a medical device
- class iii medical devices
- contact us
- contact us
- cstb life
- careers
- links
shenzhen headquarters
address: building a17, life science industrial park, kwai chung street, dapeng new district, shenzhenshanghai headquarters
address: building 21, phase 4, shanghai international medical parknational hotline:400-808-7208
scan on us
©尊龙凯时 copyright shenzhen tissue bank precision medicine co., ltd. 尊龙凯时 copyright